Sheffield among first to adopt innovative heart procedure for common heart condition

Sheffield Teaching Hospitals NHS Foundation Trust has become one of the first NHS Trusts in the UK to use a new cutting-edge therapy that can treat atrial fibrillation without the need for a general anaesthetic. 

The new Volt pulsed field ablation (PFA) procedure works by delivering short bursts of ultra-fast high-energy electrical pulses to malfunctioning heart cells. 

The team were one of the first to use the innovative technology to treat atrial fibrillation. Pictured with a (much larger!) replica of the balloon-based catheter placeholder image
The team were one of the first to use the innovative technology to treat atrial fibrillation. Pictured with a (much larger!) replica of the balloon-based catheter | Sheffield Teaching Hospitals NHS Foundation Trust/Abbott

Patients undergoing the procedure are the first to be able to have pulsed field cardiac ablation whilst conscious or under light sedation, allowing for faster and quicker recovery. 

Real-time 3D heart mapping and a balloon-in-basket catheter device, which reaches the heart via a small incision at the top of the leg, allows doctors to maximise energy to the heart whilst also minimising the risk of damage to surrounding areas. 

placeholder image

Novel heart treatment

Atrial fibrillation is the most common heart rhythm disorder in the UK, affecting around 1.5 million people.

Initial treatments involve the use of medications and blood thinners. However, when these fail many patients rely on minimally invasive cardiac ablation to prevent irregular heart rhythms – a procedure that, up until now, has typically required a general anaesthetic. 

Steven Holmes, 54, who was diagnosed with atrial fibrillation in 2021, was the first patient in Sheffield – and one of the first in the UK – to undergo the pioneering procedure.

Prior to his diagnosis he said he'd "never heard" of atrial fibrillation, which causes an irregular and often abnormally fast heart rate leading to debilitating symptoms such as fatigue and dizziness.

 “The first time it happened I was sat in the kitchen working on my laptop and my heart started racing. I could literally see my heart moving under my t-shirt. My wife took me to A&E, and the ECG showed my heart was at abnormally high 186 beats per minute.” 

“I get these flutters four or five times a year, and there are periods when it just sets off and it can go on for 45 minutes. I think the most I had it for was 13 hours. 

"I do a lot of travelling with my job as head of recruitment at Sheffield United, and there were moments when it set off and I would have to turn the car around or leave the game at half-time and go home."

Despite taking his meds, Steven continued to suffer with breathlessness, brain fog and fatigue, with his condition getting progressively worse, putting him at higher risk of stroke, heart failure and other cardiovascular complications.

"It was starting to get to the point where I was having a couple of episodes in the space of a few months and the longer you’ve got it the more dangerous it can become.” 

NHS 'couldn't do enough for me'

Steven's consultant told him there was a new procedure on the horizon - and it might just be rolled out in time for him to benefit.

In February, Steven became the first in the region to have the procedure at Sheffield's Northern General Hospital, and he was back at work almost straight afterwards.

Consultant cardiologist Dr Nicholas Kelland led the team in Sheffield, making them among the first in the UK to successfully use this new technology.

“We are proud to be among the first in the UK to offer this revolutionary technique to our patients," he explained.

"This is the first treatment that enables this type of procedure to be done without a general anaesthetic, with the ablation itself taking just 30 minutes. Not only is this good for patients, allowing for faster recovery, better outcomes and same-day discharge, but it is good for the wider NHS as this helps us to free up valuable anaesthesia and surgical resource, reducing waiting lists and enabling even more people to access vital treatments and care.” 

Sheffield is one of 15 NHS Trusts in the UK to become an early adopter of the new VoltTM PFA system, provided by global healthcare company Abbott. 

News you can trust since 1887
Follow us
© 2026 Iconic Media Group Ltd. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice